Showing 1 - 6 results of 6 for search 'Alja Stel', query time: 0.04s Refine Results
  1. 1
    Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren’s disease

    Systemic disease activity measured with ESSDAI varies largely over 5 years in a prospective, longitudinal cohort of patients with Sjögren’s disease by Suzanne Arends, Arjan Vissink, Hendrika Bootsma, Liseth de Wolff, Gwenny Verstappen, Alja Stel, Greetje van Zuiden, Jolien van Nimwegen, Frans Kroese

    Published 2025-01-01
    Get full text
    Article
  2. 2
    Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud’s Phenomenon in the Lifelines Population: Focus on Pulmonary Complications

    Self-Reported Systemic Sclerosis-Related Symptoms Are More Prevalent in Subjects with Raynaud’s Phenomenon in the Lifelines Population: Focus on Pulmonary Complications by Saskia Corine van de Zande, Amaal Eman Abdulle, Yehya Al-Adwi, Alja Stel, Karina de Leeuw, Elisabeth Brouwer, Suzanne Arends, Christiaan Tji Gan, Harry van Goor, Douwe Johannes Mulder

    Published 2023-06-01
    Get full text
    Article
  3. 3
    Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis

    Release of High-Mobility Group Box-1 after a Raynaud’s Attack Leads to Fibroblast Activation and Interferon-γ Induced Protein-10 Production: Role in Systemic Sclerosis Pathogenesis... by Yehya Al-Adwi, Isabella M. Atzeni, Berber Doornbos-van der Meer, Amaal Eman Abdulle, Anniek M. van Roon, Alja Stel, Harry van Goor, Andries J. Smit, Johanna Westra, Douwe J. Mulder

    Published 2023-03-01
    Get full text
    Article
  4. 4
    The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis

    The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis by Isabella M. Atzeni, Yehya Al-Adwi, Berber Doornbos-van der Meer, Caroline Roozendaal, Alja Stel, Harry van Goor, C. Tji Gan, Michael Dickinson, Wim Timens, Andries J. Smit, Johanna Westra, Douwe J. Mulder

    Published 2023-06-01
    Get full text
    Article
  5. 5
    High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studiesResearch in context

    High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observation... by Yehya Al-Adwi, Isabella Maria Atzeni, Berber Doornbos-van der Meer, Marcel John van der Leij, Rita Delphine Maiko Varkevisser, Bart-Jan Kroesen, Alja Stel, Wim Timens, Christiaan Tji Gan, Harry van Goor, Johanna Westra, Douwe Johannes Mulder

    Published 2023-12-01
    Get full text
    Article
  6. 6
    Reliability Exercise of Ultrasound Salivary Glands in Sjögren’s Disease: An International Web Training Initiative

    Reliability Exercise of Ultrasound Salivary Glands in Sjögren’s Disease: An International Web Training Initiative by Baptiste Quéré, Alain Saraux, Guillermo Carvajal-Alegria, Dewi Guellec, Gaël Mouterde, Christophe Lamotte, Daniel Hammenfors, Malin Jonsson, Sung-Eun Choi, Min Hong-Ki, Alja Stel, Benjamin A. Fisher, Mark Maybury, Benedikt Hofauer, Francesco Ferro, Vera Milic, Dana Direnzo, Valérie Devauchelle-Pensec, Sandrine Jousse-Joulin

    Published 2024-02-01
    Get full text
    Article

Search Tools: